Product Specifications This is a pre-formulated research blend
Dosing typically begins at a lower dose, suggested initiation of 4 units (0.04 mL) weekly for the first 4 weeks, then escalates according to a titration schedule: Weeks 1-4: Inject 4 units (0.04 mL) one time per week Weeks 5-8: Inject 8 units (0.08 mL) one time per week Weeks 9-12: Inject 18 units (0.18 mL) one time per week Weeks 13-16: Inject 30 units (0.3 mL) one time per week Week 16+: Inject 44 units (0.44 mL) one time per week Dosing may deviate from this pattern to accommodate patient-specific needs
Experimental performance: MJH, HTL, HYH, and YL
Cynara Carnitine 20%.colymus 2%
Close monitoring over time Regular followup visits to track weight, body composition, labs, blood pressure, and side effects
Generic Victoza was approved in 2024 and generic Saxenda the following year